IRONWOOD PHARMACEUTICALS, INC. Increase (Decrease) in Restricted Cash
IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Increase (Decrease) in Restricted Cash of -$1.19 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-22.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2018-02-22
- IRONWOOD PHARMACEUTICALS, INC. increase (decrease) in restricted cash for the quarter ending 2017-12-31 was $0.00.
- IRONWOOD PHARMACEUTICALS, INC. increase (decrease) in restricted cash for the quarter ending 2017-09-30 was $0.00.
- IRONWOOD PHARMACEUTICALS, INC. increase (decrease) in restricted cash for the quarter ending 2016-12-31 was $0.00.
- IRONWOOD PHARMACEUTICALS, INC. increase (decrease) in restricted cash for the quarter ending 2016-09-30 was $0.00.
- IRONWOOD PHARMACEUTICALS, INC. increase (decrease) in restricted cash for fiscal 2017 was -$1.19M.
- IRONWOOD PHARMACEUTICALS, INC. increase (decrease) in restricted cash for fiscal 2016 was -$500.00K, a 183.33% decline from fiscal 2015.
- IRONWOOD PHARMACEUTICALS, INC. increase (decrease) in restricted cash for fiscal 2015 was $600.00K.
- IRONWOOD PHARMACEUTICALS, INC. increase (decrease) in restricted cash for fiscal 2013 was $500.00K.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $0.00 derived: sum of 2 quarters · filed 2018-02-22 | -$1.19M 10-K · filed 2018-02-22 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | -$1.19M 10-Q · filed 2017-11-02 | ||
| 2017-06-30 | -$1.19M 10-Q · filed 2017-08-03 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $0.00 derived: sum of 2 quarters · filed 2018-02-22 | -$500.00K 10-K · filed 2018-02-22 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | -$500.00K 10-Q · filed 2017-11-02 | ||
| 2016-06-30 | -$500.00K 10-Q · filed 2017-08-03 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $600.00K 10-K · filed 2018-02-22 | ||
| 2015-09-30 | $600.00K 10-Q · filed 2016-11-07 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $0.00 derived: sum of 2 quarters · filed 2016-02-19 | $0.00 derived: sum of 3 quarters · filed 2016-02-19 | $500.00K 10-K · filed 2016-02-19 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $0.00 derived: sum of 2 quarters · filed 2014-11-05 | $500.00K 10-Q · filed 2014-11-05 | |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $500.00K 10-Q · filed 2014-08-05 | ||
| 2013-03-31 | $500.00K 10-Q · filed 2014-04-29 | |||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-07 | $0.00 derived: sum of 2 quarters · filed 2014-02-07 | $0.00 derived: sum of 3 quarters · filed 2014-02-07 | -$2.83M 10-K · filed 2014-02-07 |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $0.00 derived: sum of 2 quarters · filed 2012-11-06 | -$2.83M 10-Q · filed 2012-11-06 | -$2.83M derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | -$2.83M 10-Q · filed 2012-08-07 | -$2.83M derived: sum of 3 quarters · filed 2013-02-21 | -$2.83M derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-03-31 | -$2.83M 10-Q · filed 2012-05-10 | -$2.83M derived: sum of 2 quarters · filed 2013-02-21 | -$2.83M derived: sum of 3 quarters · filed 2013-02-21 | |
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $0.00 derived: sum of 2 quarters · filed 2013-02-21 | $2.35M 10-K · filed 2013-02-21 | |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $2.35M 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | $2.35M 10-Q · filed 2011-08-12 | |||
| 2009-12-31 | $446.00K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |